Hudson Bay Capital Management LP Raised Position in Bio Techne Corp (TECH) by $6.00 Million

Bio-Techne Corporation (NASDAQ:TECH) LogoInvestors sentiment increased to 1.44 in Q2 2019. Its up 0.21, from 1.23 in 2019Q1. It is positive, as 16 investors sold TECH shares while 88 reduced holdings. 51 funds opened positions while 99 raised stakes. 34.46 million shares or 0.32% less from 34.57 million shares in 2019Q1 were reported. Fred Alger Inc stated it has 0.58% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH). Redmond Asset Mgmt Limited Liability Corporation reported 7,274 shares or 0.65% of all its holdings. Cwm Ltd Liability Co reported 9 shares or 0% of all its holdings. State Treasurer State Of Michigan owns 0.02% invested in Bio-Techne Corporation (NASDAQ:TECH) for 11,200 shares. Swiss Commercial Bank reported 0.02% in Bio-Techne Corporation (NASDAQ:TECH). Hightower Advsr Ltd Limited Liability Company has invested 0% in Bio-Techne Corporation (NASDAQ:TECH). Thrivent Finance For Lutherans has invested 0.06% in Bio-Techne Corporation (NASDAQ:TECH). The Maine-based Schroder Investment Grp Incorporated has invested 0.03% in Bio-Techne Corporation (NASDAQ:TECH). Svcs Automobile Association holds 0.01% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH) for 17,239 shares. Geode Ltd Liability has invested 0.02% in Bio-Techne Corporation (NASDAQ:TECH). Wms Partners Limited Liability owns 1,039 shares for 0.05% of their portfolio. Price T Rowe Md owns 20,161 shares. Voya Invest Ltd Limited Liability Company has 13,639 shares for 0.01% of their portfolio. First Advisors LP holds 0.24% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH) for 620,787 shares. 4,725 were reported by Oakbrook Lc.

Since August 7, 2019, it had 2 buys, and 0 selling transactions for $132,530 activity. The insider BAUMGARTNER ROBERT V bought 500 shares worth $95,530.

Hudson Bay Capital Management Lp increased its stake in Bio Techne Corp (TECH) by 200% based on its latest 2019Q2 regulatory filing with the SEC. Hudson Bay Capital Management Lp bought 50,000 shares as the company’s stock rose 3.97% . The hedge fund held 75,000 shares of the biological products (no diagnostic substances) company at the end of 2019Q2, valued at $9.07M, up from 25,000 at the end of the previous reported quarter. Hudson Bay Capital Management Lp who had been investing in Bio Techne Corp for a number of months, seems to be bullish on the $7.61B market cap company. The stock increased 0.73% or $1.46 during the last trading session, reaching $200.95. About 84,483 shares traded. Bio-Techne Corporation (NASDAQ:TECH) has risen 33.52% since October 12, 2018 and is uptrending. It has outperformed by 33.52% the S&P500.

Hudson Bay Capital Management Lp, which manages about $4.18B and $4.02 billion US Long portfolio, decreased its stake in Avista Healthcare Public Acq Co by 1.10M shares to 900,000 shares, valued at $9.31 million in 2019Q2, according to the filing. It also reduced its holding in Bard C R Inc (NYSE:BCR) by 25,000 shares in the quarter, leaving it with 61,180 shares, and cut its stake in Micron Technology Inc (Prn).

More notable recent Bio-Techne Corporation (NASDAQ:TECH) news were published by: Nasdaq.com which released: “Cisco Stock Downgraded by Goldman Sachs on Slowdown Fears – Nasdaq” on October 10, 2019, also Etftrends.com with their article: “”China’s Nasdaq” Could Pave Way for More China Tech ETF Gains – ETF Trends” published on September 29, 2019, Nasdaq.com published: “Technology Sector Update for 10/03/2019: SNAP,FB,CRWD,SFET,GPRO – Nasdaq” on October 03, 2019. More interesting news about Bio-Techne Corporation (NASDAQ:TECH) were released by: Nasdaq.com and their article: “ETF Areas to Shine on ‘Very Good’ Trade Negotiation – Nasdaq” published on October 11, 2019 as well as Nasdaq.com‘s news article titled: “Why Universal Display Shares Dropped 18% Last Month – Nasdaq” with publication date: October 09, 2019.

Bio-Techne Corporation (NASDAQ:TECH) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.